1
Discover top-quality products tailored for scientific and medical research. Request a personalized quote today
to enhance your projects.
Species | Human |
Cat.No | ABC-TC3706 |
Quality Control | All cells test negative for mycoplasma, bacteria, yeast, and fungi. |
Product Category | Primary Cells |
Size/Quantity | 1 vial |
Cell Type | Progenitor Cell |
Shipping Info | Dry Ice |
Growth Conditions | 37 ℃, 5% CO2 |
Source Organ | Peripheral Blood |
Disease | Normal |
Biosafety Level | 1 |
Storage | Liquid Nitrogen |
Product Type | Immune Cells |
Human Mobilized Peripheral Blood CD34+ Progenitor Cells are a type of hematopoietic stem and progenitor cells isolated from human peripheral blood after mobilization treatment. These cells, collected from healthy donors, are highly enriched for the CD34—the classical marker of hematopoietic stem and progenitor cells. They exhibit robust proliferation and multilineage differentiation potential, capable of generating various blood cell types including erythroid, myeloid, and lymphoid lineages under appropriate conditions. These cells represent a critical resource for research in hematopoietic reconstitution, gene therapy, toxicology, and stem cell biology.
When you publish your research, please cite our product as “AcceGen Biotech Cat.# XXX-0000”. In return, we’ll give you a $100 coupon. Simply click here and submit your paper’s PubMed ID (PMID).
CD34+ cells are multipotent hematopoietic stem and progenitor cells used extensively in blood and immune system research. They support investigations into hematopoiesis, disease modeling for blood-related disorders, and the evaluation of drugs affecting blood cell development. This makes CD34+ cells essential tools for stem cell biology, regenerative medicine, and the study of leukemia and other hematologic diseases.